The current KNSA market cap is 1.41B. The company's latest EPS is USD 0.1951 and P/E is 100.21.
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | 38.54M | 220.18M | 270.26M |
Operating Income | -169.96M | -157.36M | -156.64M | 9.77M | -25.2M |
Net Income | -161.87M | -161.38M | -157.92M | 183.36M | 14.08M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 254.53M | 349.46M | 232.8M | 459.67M | 526.32M |
Total Liabilities | 29.11M | 37.53M | 47.76M | 63.52M | 87.48M |
Total Equity | 225.42M | 311.94M | 185.04M | 396.15M | 438.84M |
Market Cap | 1.41B |
Price to Earnings Ratio | 100.21 |
Price to Sales Ratio | 5.22 |
Price to Cash Ratio | 13.08 |
Price to Book Ratio | 3.22 |
Dividend Yield | - |
Shares Outstanding | 72.2M |
Average Volume (1 week) | 341.31k |
Average Volume (1 Month) | 611.39k |
52 Week Change | -1.46% |
52 Week High | 28.15 |
52 Week Low | 16.56 |
Spread (Intraday) | 10.39 (37.11%) |
Company Name | Kiniksa Pharmaceuticals International PLC |
Address |
third floor london W1S 4PZ |
Website | https://www.kiniksa.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions